ABO blood group and the risk of post-thrombotic syndrome
Post-thrombotic syndrome (PTS) has been associated to DVT recurrence, increased FVIII, inflammatory biomarker plasma levels, and persistence of vein obstruction. These same features have also been widely reported in non-O blood type subjects. Our aim was to investigate the correlation between the in...
Gespeichert in:
| Veröffentlicht in: | Annals of hematology 2018-06, Vol.97 (6), p.1057-1060 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1060 |
|---|---|
| container_issue | 6 |
| container_start_page | 1057 |
| container_title | Annals of hematology |
| container_volume | 97 |
| creator | Spiezia, Luca Campello, Elena Valle, Fabio Dalla Simion, Chiara Colpo, Anna Simioni, Paolo |
| description | Post-thrombotic syndrome (PTS) has been associated to DVT recurrence, increased FVIII, inflammatory biomarker plasma levels, and persistence of vein obstruction. These same features have also been widely reported in non-O blood type subjects. Our aim was to investigate the correlation between the incidence of PTS and ABO blood types. Consecutive patients referred to the Department of Medicine of University of Padua between January 2004 and January 2012 following the diagnosis of a first episode of proximal DVT were enrolled. The presence of PTS was assessed via the Villalta scale at predefined time points (3, 6, 12, 18, 24, 36 months). Hazard ratio (HR) for PTS development was calculated in non-O (exposed) vs O blood (unexposed) type patients. Out of 671 eligible patients, 606 were enrolled. Overall, 192 (31.7%) patients developed PTS: 142 (34.5%) non-O and 50 (25.6%) O blood type patients. Individuals with non-O blood group were associated with a significantly higher risk to develop PTS (HR 1.53, 95% CI, 1.05–2.24;
p
= 0.028) than O group. Non-O blood type might be a risk factor for the development of PTS. |
| doi_str_mv | 10.1007/s00277-018-3255-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1993387286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1993596537</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-64b4d1d4d456b20e5217d883ba96e65250374a2d891343a90c3187517931894d3</originalsourceid><addsrcrecordid>eNp1kLtOwzAUhi0EoqXwACzIEguLwdfYHkvFTarUBWYrid02pYmDnQx9e1xSEELCy5F1vvPb5wPgkuBbgrG8ixhTKREmCjEqBGJHYEw4owgLxY_BGGumkUhnBM5i3GBMqOL0FIyoZkpqmY2Bmt4vYLH13sJV8H0L88bCbu1gqOI79EvY-tihbh18XfiuKmHcNTZd3Dk4Webb6C4OdQLeHh9eZ89ovnh6mU3nqGSSdijjBbfEcstFVlDsBCXSKsWKXGcuE1RgJnlOrdKEcZZrXDKipCBSp6q5ZRNwM-S2wX_0LnamrmLpttu8cb6PhmjN0jJUZQm9_oNufB-a9LsvSuhMMJkoMlBl8DEGtzRtqOo87AzBZq_VDFpN0mr2Wg1LM1eH5L6onf2Z-PaYADoAMbWalQu_nv439ROG4X7H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1993596537</pqid></control><display><type>article</type><title>ABO blood group and the risk of post-thrombotic syndrome</title><source>Springer Nature - Complete Springer Journals</source><creator>Spiezia, Luca ; Campello, Elena ; Valle, Fabio Dalla ; Simion, Chiara ; Colpo, Anna ; Simioni, Paolo</creator><creatorcontrib>Spiezia, Luca ; Campello, Elena ; Valle, Fabio Dalla ; Simion, Chiara ; Colpo, Anna ; Simioni, Paolo</creatorcontrib><description>Post-thrombotic syndrome (PTS) has been associated to DVT recurrence, increased FVIII, inflammatory biomarker plasma levels, and persistence of vein obstruction. These same features have also been widely reported in non-O blood type subjects. Our aim was to investigate the correlation between the incidence of PTS and ABO blood types. Consecutive patients referred to the Department of Medicine of University of Padua between January 2004 and January 2012 following the diagnosis of a first episode of proximal DVT were enrolled. The presence of PTS was assessed via the Villalta scale at predefined time points (3, 6, 12, 18, 24, 36 months). Hazard ratio (HR) for PTS development was calculated in non-O (exposed) vs O blood (unexposed) type patients. Out of 671 eligible patients, 606 were enrolled. Overall, 192 (31.7%) patients developed PTS: 142 (34.5%) non-O and 50 (25.6%) O blood type patients. Individuals with non-O blood group were associated with a significantly higher risk to develop PTS (HR 1.53, 95% CI, 1.05–2.24;
p
= 0.028) than O group. Non-O blood type might be a risk factor for the development of PTS.</description><identifier>ISSN: 0939-5555</identifier><identifier>EISSN: 1432-0584</identifier><identifier>DOI: 10.1007/s00277-018-3255-3</identifier><identifier>PMID: 29387976</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Blood groups ; Hematology ; Medicine ; Medicine & Public Health ; Oncology ; Original Article</subject><ispartof>Annals of hematology, 2018-06, Vol.97 (6), p.1057-1060</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><rights>Annals of Hematology is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-64b4d1d4d456b20e5217d883ba96e65250374a2d891343a90c3187517931894d3</citedby><cites>FETCH-LOGICAL-c372t-64b4d1d4d456b20e5217d883ba96e65250374a2d891343a90c3187517931894d3</cites><orcidid>0000-0003-4339-8525</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00277-018-3255-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00277-018-3255-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29387976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spiezia, Luca</creatorcontrib><creatorcontrib>Campello, Elena</creatorcontrib><creatorcontrib>Valle, Fabio Dalla</creatorcontrib><creatorcontrib>Simion, Chiara</creatorcontrib><creatorcontrib>Colpo, Anna</creatorcontrib><creatorcontrib>Simioni, Paolo</creatorcontrib><title>ABO blood group and the risk of post-thrombotic syndrome</title><title>Annals of hematology</title><addtitle>Ann Hematol</addtitle><addtitle>Ann Hematol</addtitle><description>Post-thrombotic syndrome (PTS) has been associated to DVT recurrence, increased FVIII, inflammatory biomarker plasma levels, and persistence of vein obstruction. These same features have also been widely reported in non-O blood type subjects. Our aim was to investigate the correlation between the incidence of PTS and ABO blood types. Consecutive patients referred to the Department of Medicine of University of Padua between January 2004 and January 2012 following the diagnosis of a first episode of proximal DVT were enrolled. The presence of PTS was assessed via the Villalta scale at predefined time points (3, 6, 12, 18, 24, 36 months). Hazard ratio (HR) for PTS development was calculated in non-O (exposed) vs O blood (unexposed) type patients. Out of 671 eligible patients, 606 were enrolled. Overall, 192 (31.7%) patients developed PTS: 142 (34.5%) non-O and 50 (25.6%) O blood type patients. Individuals with non-O blood group were associated with a significantly higher risk to develop PTS (HR 1.53, 95% CI, 1.05–2.24;
p
= 0.028) than O group. Non-O blood type might be a risk factor for the development of PTS.</description><subject>Blood groups</subject><subject>Hematology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Original Article</subject><issn>0939-5555</issn><issn>1432-0584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kLtOwzAUhi0EoqXwACzIEguLwdfYHkvFTarUBWYrid02pYmDnQx9e1xSEELCy5F1vvPb5wPgkuBbgrG8ixhTKREmCjEqBGJHYEw4owgLxY_BGGumkUhnBM5i3GBMqOL0FIyoZkpqmY2Bmt4vYLH13sJV8H0L88bCbu1gqOI79EvY-tihbh18XfiuKmHcNTZd3Dk4Webb6C4OdQLeHh9eZ89ovnh6mU3nqGSSdijjBbfEcstFVlDsBCXSKsWKXGcuE1RgJnlOrdKEcZZrXDKipCBSp6q5ZRNwM-S2wX_0LnamrmLpttu8cb6PhmjN0jJUZQm9_oNufB-a9LsvSuhMMJkoMlBl8DEGtzRtqOo87AzBZq_VDFpN0mr2Wg1LM1eH5L6onf2Z-PaYADoAMbWalQu_nv439ROG4X7H</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Spiezia, Luca</creator><creator>Campello, Elena</creator><creator>Valle, Fabio Dalla</creator><creator>Simion, Chiara</creator><creator>Colpo, Anna</creator><creator>Simioni, Paolo</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4339-8525</orcidid></search><sort><creationdate>20180601</creationdate><title>ABO blood group and the risk of post-thrombotic syndrome</title><author>Spiezia, Luca ; Campello, Elena ; Valle, Fabio Dalla ; Simion, Chiara ; Colpo, Anna ; Simioni, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-64b4d1d4d456b20e5217d883ba96e65250374a2d891343a90c3187517931894d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Blood groups</topic><topic>Hematology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Original Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spiezia, Luca</creatorcontrib><creatorcontrib>Campello, Elena</creatorcontrib><creatorcontrib>Valle, Fabio Dalla</creatorcontrib><creatorcontrib>Simion, Chiara</creatorcontrib><creatorcontrib>Colpo, Anna</creatorcontrib><creatorcontrib>Simioni, Paolo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spiezia, Luca</au><au>Campello, Elena</au><au>Valle, Fabio Dalla</au><au>Simion, Chiara</au><au>Colpo, Anna</au><au>Simioni, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ABO blood group and the risk of post-thrombotic syndrome</atitle><jtitle>Annals of hematology</jtitle><stitle>Ann Hematol</stitle><addtitle>Ann Hematol</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>97</volume><issue>6</issue><spage>1057</spage><epage>1060</epage><pages>1057-1060</pages><issn>0939-5555</issn><eissn>1432-0584</eissn><abstract>Post-thrombotic syndrome (PTS) has been associated to DVT recurrence, increased FVIII, inflammatory biomarker plasma levels, and persistence of vein obstruction. These same features have also been widely reported in non-O blood type subjects. Our aim was to investigate the correlation between the incidence of PTS and ABO blood types. Consecutive patients referred to the Department of Medicine of University of Padua between January 2004 and January 2012 following the diagnosis of a first episode of proximal DVT were enrolled. The presence of PTS was assessed via the Villalta scale at predefined time points (3, 6, 12, 18, 24, 36 months). Hazard ratio (HR) for PTS development was calculated in non-O (exposed) vs O blood (unexposed) type patients. Out of 671 eligible patients, 606 were enrolled. Overall, 192 (31.7%) patients developed PTS: 142 (34.5%) non-O and 50 (25.6%) O blood type patients. Individuals with non-O blood group were associated with a significantly higher risk to develop PTS (HR 1.53, 95% CI, 1.05–2.24;
p
= 0.028) than O group. Non-O blood type might be a risk factor for the development of PTS.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>29387976</pmid><doi>10.1007/s00277-018-3255-3</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-4339-8525</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0939-5555 |
| ispartof | Annals of hematology, 2018-06, Vol.97 (6), p.1057-1060 |
| issn | 0939-5555 1432-0584 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1993387286 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Blood groups Hematology Medicine Medicine & Public Health Oncology Original Article |
| title | ABO blood group and the risk of post-thrombotic syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T21%3A12%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ABO%20blood%20group%20and%20the%20risk%20of%20post-thrombotic%20syndrome&rft.jtitle=Annals%20of%20hematology&rft.au=Spiezia,%20Luca&rft.date=2018-06-01&rft.volume=97&rft.issue=6&rft.spage=1057&rft.epage=1060&rft.pages=1057-1060&rft.issn=0939-5555&rft.eissn=1432-0584&rft_id=info:doi/10.1007/s00277-018-3255-3&rft_dat=%3Cproquest_cross%3E1993596537%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1993596537&rft_id=info:pmid/29387976&rfr_iscdi=true |